Head, North America Vaccines
Kimberly Tutwiler is the Head of North America Vaccines at Sanofi. Based in Morristown, New Jersey, she leads Sanofi's North America Vaccines organization, overseeing the strategic direction and operational performance of the company's vaccines portfolio in the U.S. and Canada. Kimberly is a member of the Vaccines Executive Committee and the Sanofi U.S. Country Council, working closely with cross-functional teams to advance the company's mission to protect lives through innovative vaccine solutions.
Kimberly brings more than 25 years of experience in the vaccines and healthcare industry, with a career spanning sales, sales management, training and development, and marketing roles in the U.S. and globally including leading the global launch of Beyfortus, Sanofi’s immunization to protect all infants from respiratory syncytial virus (RSV). She rejoins the Vaccines organization from her most recent role as Global Head of Therapeutic Area Respiratory, Specialty Care Dupixent, at Sanofi.
Kimberly graduated from Denison University with a BA in Political Science and an Executive MBA from Villanova.
Throughout her career, Kimberly has built a reputation as a trusted leader known for driving commercial excellence, executing complex launches, and partnering with key stakeholders to advance public health and patient impact.